IMPACT- Renal watch


Protocolnummer:
NL44748.091.13

Ziekenhuizen:
RadboudUMC Nijmegen
TweeSteden Waalwijk
Universitair Medisch Centrum Groningen
VU Medisch Centrum Amsterdam

Titel:
Watchful waiting in patients with good and intermediate risk metastatic renal cell carcinoma; an imaging guided observational approach

Behandeling:

Stadium:

Belangrijkste in/exclusiecriteria:
In: Histological or cytological documented RCC with a clear cell component,, Good or intermediate prognosis, defined as none (good risk) or 1-2 (intermediate risk), A watchful waiting period for 2 months is considered an option according to treating medical oncologist, No prior systemic treatment for RCC (also non-adjuvant) Ex: Untreated central nervous system metastases, or symptomatic intracerebral metastases, Any serious and/or unstable pre-existing medical, psychiatric, or other condition that would make the subject inappropriate for study participation including any serious condition that could interfere with subject’s safety, provision of informed consent, or compliance with study procedure.

Contactpersoon:

Alle trials